Our observation that T2DM subjects with varying levels of obesity (Groups B to D) showed significantly lower CCL5 levels, irrespective of gender, as compared to T2DM subjects with normal body weight (Group A), is somewhat bewildering and we do not have any concrete explanation for this phenomenon. This evidence concerns the gene CCL5 and obesity disorder.